Chem. J. Chinese Universities ›› 2022, Vol. 43 ›› Issue (12): 20220383.doi: 10.7503/cjcu20220383

• Review • Previous Articles     Next Articles

Recent Advances in Lipid-responsive Probes in the Imaging and Treatment of Atherosclerosis

XU Xinyu, ZHANG Letian, CAO Hui, MA Yuan, LIU Liuhui, SONG Guosheng(), ZHANG Xiaobing()   

  1. State Key Laboratory of Chemo/Biosensing and Chemometrics,College of Chemistry and Chemical Engineering,Hunan University,Changsha 410082,China
  • Received:2022-05-30 Online:2022-12-10 Published:2022-07-26
  • Contact: SONG Guosheng, ZHANG Xiaobing E-mail:songgs@hnu.edu.cn;xbzhang@hnu.edu.cn
  • Supported by:
    the National Key Research and Development Program of China(2019YFA0210100);the National Natural Science Foundation of China(21890744);the Science and Technology Project of Hunan Province, China(2020RC3022)

Abstract:

Atherosclerosis(AS) is one of the main threats of cardiovascular diseases(CVDs) and may lead to a series of serious adverse consequences such as acute coronary syndromes(e.g., acute myocardial infarction), stroke, and even sudden death. Abnormal accumulation of lipids is one of the signatures of AS, and it is necessary to observe their quantity, localization, and distribution in vivo. Fluorescent probes with the advantages of high operability, high spatial and temporal resolution, and good biocompatibility are expected to be favorable tools for understanding lipid function in AS. This review summarizes lipid droplet(LD)-specific optical imaging probes based on organic framework structures such as rhodamine, coumarin, dipyrromethene boron difluoride(BODIPY), 1,8-naphthalimide, and metal complex probes, and highlights their applications in atherosclerotic plaque imaging, imaging-guided surgery and therapy. Finally, a summary and outlook on the field are presented, hoping to provide useful references for related research.

Key words: Fluorescent probe, Lipid droplet imaging, Atherosclerosis

CLC Number: 

TrendMD: